Market-Moving News for October 8th
Market-Moving News for October 8th
BPTH: 74% | Bio-Path Has Initiated A Therapeutic Program To Develop BP1001-A For Obesity And Related Metabolic Diseases, This Program Marks The First Application Of DNAbilize Technology For Development Of A Non-cancer Application
BPTH: 74% | Bio-Path已啓動治療計劃，開發BP1001-A用於肥胖和相關代謝性疾病，這個計劃標誌着DNAbilize 科技首次應用於非癌症應用的開發。
DOCU: 6% | DocuSign shares are trading higher after it was announced the company will join the S&P MidCap 400.
DOCU: 6% | DocuSign股票上漲，因公司宣佈將加入S&P MidCap 400指數。
SAGE: -26% | Sage Therapeutics shares are trading lower after the company stops further development of dalzanemdor in Alzheimer's Disease following disappointing results from the Phase 2 LIGHTWAVE Study.
SAGE: -26% | sage therapeutics股票下跌，因公司決定停止在阿爾茨海默症中進一步開發dalzanemdor，此舉是基於第2期LIGHTWAVE研究結果令人失望。
譯文內容由第三人軟體翻譯。
